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ABSTRACT 
Objective: Ash and its preparations have been used in Ayurveda for the treatment of various ailments since 7th century AD. Numerous studies 
suggest that the elements present in ash have significant role in affective disorders. Thus, the present study aimed at evaluating the antianxiety and 
antidepressant activity of total ash of H. sabdariffa calyces, and also of the tablets of total ash.  
Methods: Powdered calyces were taken in tared silica crucible, and were incinerated at a temperature not exceeding 450 °C. The resultant ash was 
cooled and weighed. This was evaluated for antianxiety and antidepressant activity using an elevated plus maze and Porsolt’s swim test, 
respectively. Further, the ash samples were analysed through ICP-MS to know their composition. The ash was formulated into tablets using the wet 
granulation technique, using only organic excipients.  
Results: Results indicated that the total ash of H. sabdariffa calyces exhibited significant (p<0.001) antianxiety and antidepressant activity at 50 and 
100 mg/kg, po, respectively. The activities were comparable to the standard drugs. ICP-MS analysis showed the presence of magnesium, 
phosphorous, potassium and calcium as major elements. Tablets of H. sabdariffa total ash were as effective (p<0.001) as the total ash. 
Conclusion: Magnesium, phosphorous, potassium and calcium have been reported to play a significant role in affective disorders, explaining, 
thereby, as to why ash of H. sabdariffa calyces exhibited anti-anxiety and antidepressant activity. 
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INTRODUCTION  
Affective disorders, especially anxiety and depression are among the 
most common psychiatric problems globally, with prevalence rates 
of 3.6 % and 4.4 %, respectively [1]. Anxiety is a frequent negative 
emotional state, manifested as unsettling feeling of concern or worry 
that is displayed by worried facial expressions and bodily responses 
like muscle tension, restlessness, impaired concentration, sleep 
disturbances and irritability [2]. Depression is characterized by 
recurring episodes of dysphoria and negative thinking that is 
reflected in behaviour [3]. Over the years, relationship between 
anxiety and depression has been extensively examined, and studies 
show that anxiety often precedes depressive disorders. Reported 
percentage comorbidity for anxiety and depression is estimated to be 
70 % [4]. A wide range of therapeutic drugs are available for treatment 
of anxiety and depression, ranging from specific drugs like 
barbiturates, benzodiazepines to atypical drugs like buspiron as well 
as antipsychotics all of which exhibit various types of side effects [5]. 
Given the issues with current treatment options, patients are inclining 
towards complementary and alternative medicines (CAM), i.e., herbal 
remedies, meditation and spiritual practices, acupuncture and dietary 
practices; with more than 80 % of the population worldwide relying 
on herbs for the treatment of specific disorders [6, 7].  
Bhasmas/metallic preparations have been extensively employed in 
Ayurvedic and Unani systems of medicine for the treatment of 
various ailments. Bhasmas are essentially ashes obtained through 
incineration. Numerous literature reports have shown that essential 
elements present in bhasmas are involved in the neurobiological 
mechanisms of various diseases including anxiety and depression. 
Deficiencies of these essential elements are associated with the 
pathogenesis of anxiety and depression [8-10]. Thus, taking cue 
from the literature, the present study was designed to evaluate the 
antianxiety and antidepressant activity of total ash of H. sabdariffa 
calyces. Calyces of H. sabdariffa (Malvaceae), popularly known as 
Red Sorrel (English) or Lal Ambari (Hindi), have been used in folk 
medicine in the management of nervous disorders, and also as 
sedative, diuretic, diaphoretic, choleretic, laxative, antifungal, 
antibacterial and antitussive [11, 12]. The authors have already 
reported that the ethanol extract of H. sabdariffa calyces exhibits 
significant antianxiety and antidepressant activity in mice [13].  
MATERIALS AND METHODS 
Plant material 
Dried calyces of H. sabdariffa were procured from Earth Expo 
Company, Gujarat, India. These were authenticated by comparing 
their morphological and microscopical characters with those 
reported in the literature [14]. Voucher specimen (Number 252) of 
the calyces has been deposited in Herbarium-cum-Museum of 
University Institute of Pharmaceutical Sciences, Panjab University, 
Chandigarh. 
Preparation of ash and determination of ash values 
Powdered plant material (10 g) was taken in tared silica crucible, 
and incinerated in muffle furnace at a temperature not exceeding 
450 °C until free from carbon. The resultant ash was cooled and 
weighed. Ash values (total, acid-insoluble and water-soluble) of the 
plant material were determined, in triplicate, following the 
procedures prescribed in USP [15].  
Experimental animals 
Lacca mice (either sex), housed at the Central Animal House, Panjab 
University, were allowed standard pellet diet (Ashirwad, 
Chandigarh) and water ad libitum. Groups of 6 mice (20-30 g) were 
used in all sets of experiments. The animals were fasted for 12 h 
before use. Approval (PU/IAEC/S/16/112) from the Institutional 
Animal Ethical Committee of Panjab University, Chandigarh was 
taken before carrying out biological studies. Standard group 
received diazepam (Jawa Pharmaceuticals Pvt. Ltd., Gurugram) or 
imipramine (Torrent Pharmaceuticals, Solan, India). 
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Dosing and treatment 
Tween 80 (5%) in aqueous carboxymethylcellulose (CMC 0.5% w/w) 
was used as a vehicle for preparing the suspension of total ash. Doses 
were prepared by suspending appropriate quantities in the vehicle so 
as to administer these to mice in volumes ranging between 0.20-0.30 
ml per oral route. Mice were randomly divided into control, test and 
standard drug groups, each comprising 6 animals. Control group was 
administered vehicle only. Test groups received the suspension of total 
ash or tablets of total ash of H. sabdariffa calyces.  
Acute toxicity studies of the total ash 
Acute toxicity studies of total ash of H. sabdariffa calyces were carried 
out on mice as per OECD 423 guidelines [16]. After 12 h of fasting, 
different groups of mice were administered a single oral dose (500, 
1000 or 2000 mg/kg) of the total ash. Immediately after dosing, 
animals were observed for signs of toxicity during the first 0.5, 1, 2, 4, 
8 and 12 h, and at every 24 h for 14 d. Behavioral parameters, tremors, 
lethargy, death, amount of water and feed taken were observed. 
Antianxiety activity evaluation: elevated plus-maze model 
Antianxiety activity was evaluated using elevated plus maze (EPM) 
model [17, 18]. The apparatus consisted of two open arms (16×5 
cm) and two closed arms (16×5×12 cm) having an open roof. It was 
kept elevated (25 cm) from the floor for evaluating the anxiolytic 
behavior. Doses were administered orally using tuberculin syringe 
fitted with an oral cannula. The dose administration schedule was so 
adjusted that each mouse was having its turn on the EPM 60 min 
after the administration of the vehicle, diazepam or the test 
substance. Each mouse was placed at the centre of EPM with its head 
facing towards the open arm. During 5 min duration of the 
experiment, the behavior of the mouse was recorded as (a) the 
number of entries into the open arms and (b) mean time spent by 
the mouse in open arms. The arms of EPM were cleaned using 
ethanol-soaked cotton swab every time the animal was used for 
recording the results. 
Antidepresant activity evaluation: porsolt’s forced swim test  
Forced swim test (FST) was used to evaluate antidepressant activity 
[18, 19]. Mice were forced to swim in a vertical Plexiglas jar 
(25×12×25 cm) containing water upto a height of 15 cm at room 
temperature (25±1°C). Mice were administered standard 
antidepressant imipramine or the test substance 60 min before the 
evaluation. After an initial period of vigorous activity to escape, the 
animals assumed a typical immobile posture (ceased to struggle 
with minimal limb movements just sufficient to keep their head 
above the level of water). Total immobility period during 6 min 
session was noted. 
Antianxiety and antidepressant activity evaluation of total ash 
of H. sabdariffa calyces 
The total ash of H. sabdariffa calyces was evaluated for antianxiety 
and antidepressant activity using EPM and FST, respectively at the 
dose of 25, 50, 100 and 200 mg/kg, po. 
Preparation of tablets 
The total ash of H. sabdariffa calyces was formulated as tablets (50 
mg) using wet granulation technique. Ash of H. sabdariffa was mixed 
with lactose and dry starch in a polythene bag. This was followed by 
slow addition of 10 % starch paste to form a uniform mass which 
was passed through sieve (#16) and dried in hot air oven at a 
temperature not exceeding 50 °C. Dried granules were mixed with 
stearic acid and passed through a sieve (#20). The granules were 
compressed using direct compression tablet punching machine. 
Before compression, the dies and punches were lubricated with 
stearic acid. Three batches, each of hundred tablets, were prepared 
and stored in an airtight container at room temperature for further 
studies. Placebo was prepared in the similar manner. While 
preparing the tablets, it was ensured to use only organic excipients 
to prevent any elevation or diminution of activity due to the 
inorganic composition of the excipients. Both the placebo and H. 
sabdariffa total ash tablets were subjected to antianxiety and 
antidepressant activity evaluation using EPM and FST, respectively. 
Evaluation of Pre-formulation and Post-formulation parameters 
The tablet granules were subjected to pre-formulation parameters’ 
evaluation (angle of repose, bulk density, tapped density, Hausner’s 
ratio and Carr’s index) prior to compression. The prepared tablets 
were subjected to post-formulation parameters’ (visual inspection, 
hardness, friability, uniformity in weight and disintegration time). 
The ash content uniformity of the tablets was determined 
gravimetrically by incinerating 20 tablets as per the procedure for 
preparing the total ash. The content determination was performed 
in triplicate. Both pre and post-formulation parameters were 
evaluated following the procedures prescribed in USP, 2014 [15]. 
Antianxiety and antidepressant activity evaluation of tablets of 
total ash of H. sabdariffa calyces 
Placebo and H. sabdariffa total ash tablets were evaluated for antianxiety 
and antidepressant activity at dose of 50 and 100 mg/kg, respectively. 
Elemental analysis of total-ash: ICP-MS technique 
The total-ash of H. sabdariffa calyces was analyzed for quantitative 
estimation of different elements using inductively coupled plasma-
mass spectrometer (Agilent 7900, IIT Delhi).  
Antianxiety and antidepressant activity evaluation of major 
elements in total ash of H. sabdariffa calyces 
Salts of the major elements (Mg, K and Ca) present in the total ash of 
H. sabdariffa calyces were evaluated for antianxiety and 
antidepressant activity using EPM and FST, respectively. Doses of 
the salts (MgSO4, K2SO4 and CaCO3) were calculated according to the 
percentage concentration of each element present in the total ash. 
Statistical analysis  
The data have been expressed as mean±standard error of mean 
(SEM). Significant differences among the groups were assessed by 
one way analysis of variance (ANOVA) using GraphPad Prism 5. The 
test was followed by Tukey’s multiple range test; p values less than 
0.001 were considered as significant. 
RESULTS 
Determination of ash values of H. sabdariffa calyces 
Table 1 shows the results of ash value determination of H. sabdariffa 
calyces. 
 
Table 1: Ash values of the H. sabdariffa calyces 
Ash Ash values* (% w/w) (Mean#±SEM) 
Total-ash 7.19±0.008 
Acid insoluble ash 0.53±0.005 
Water-soluble ash 1.20±0.005 
*dry weight basis, #n=3 
 
Acute toxicity studies  
No toxic effects were observed in the total-ash of H. sabdariffa 
calyces up to a dose of 2000 mg/kg. 
Preparation of tablets 
Table 2 shows the formula for placebo and H. sabdariffa total ash tablets. 
 
Table 2: Formula of placebo and H. sabdariffa total ash tablets 
Ingredients Quantity per tablet (mg) 
Placebo H. sabdariffa total ash tablets 
Ash - 1 
Stearic acid 2 2 
Lactose 29 26 
Starch dry 8 6 
Starch paste q. s. q. s 
 
Pre formulation and post formulation parameters’ evaluation 
The results of pre and post formulation parameters’ evaluation are 
depicted in table 3 and 4, respectively. 
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Table 3: Results of pre-formulation parameters’ evaluation 
S. No. Parameter Placebo H. sabdariffa total-ash tablets 
Observation Inference Observation Inference 
1. Angle of repose 25.26 ° Excellent 25.52 ° Excellent 
2. Bulk density  0.47 g/ml – 0.49 g/ml – 
3. Tapped density  0.54 g/ml – 0.56 g/ml – 
4. Hausner’s ratio  1.14 Good 1.14 Good 
5. Carr’s index 12.96 % Good 12.50 % Good 
 
Table 4: Mean**±SEM values of post-formulation parameters’ evaluation 
S. No. Evaluation parameter Placebo H. sabdariffa tablets 
1. Diameter 5.08±0.005 mm 5.06±0.005 mm 
2. Thickness 2.17±0.005 mm 2.20±0.005 mm 
3. Hardness 5.60±0.005 kg/cm2 6.04±0.005 kg/cm2 
4. Friability* 0.17±0.005 % 0.19±0.005 % 
5. % weight variation# 5.30±0.005 % 4.39±0.005 % 
6. Disintegration time$ 5.40±0.005 sec 35.00±0.005 sec 
7. Drug Content Estimationand 0±0.00 mg 1±0.00 mg 
**n=3, USP, 2014 prescribed limits. *: ≤ 1 %; #:±10 %; $: ≤ 15 min; and:±10 %  
 
Antianxiety and antidepressant activity evaluation of total ash 
and its tablets of H. sabdariffa calyces 
Administration of diazepam (2 mg/kg) significantly increased the 
number of entries and the time spent in the open arms compared to 
the control group. Both the total ash of H. sabdariffa calyces and its 
tablets thereof exhibited significant antianxiety activity at a dose of 
50 mg/kg (fig. 1 and 2). Similarly, at a dose of 100 mg/kg, these 
demonstrated a statistically significant diminution of immobility 
time when the animals were subjected to FST (fig. 3 and 4). Results 
of imipramine (10 mg/kg) were similar to results of those observed 
with the total ash. 
 
 
Fig. 1: Antianxiety activity profile of total-ash of H. sabdariffa calyces using EPM. The data is expressed as mean±SEM; *n=6; ap<0.001 vs 
control; bp<0.001 vs diazepam; one way ANOVA followed by Tukey’s multiple range tests 
 
Table 5: Results of quantitative estimation of elements present in total ash of H. sabdariffa calyces by ICP-MS technique 
Element % Concentration Element % Concentration 
 Ag 0.000004 Mg 0.316655 
Al 0.029504  Mn 0.029390 
 As 0.000010  Ni 0.000339 
 Au 0.000001 P 0.020696 
 Ca 0.297205  Pb 0.000061 
 Cd 0.000009 Pt 0.000000 
 Co 0.000037  Se 0.000016 
 Cu 0.001341  Sn 0.000046 
 Fe 0.029330  Zn 0.004037 
K 1.471199 - - 
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Fig. 2: Antianxiety activity profile of Placebo and H. sabdariffa total ash tablets using EPM. The data is expressed as mean±SEM; *n=6; 
ap<0.001 vs diazepam; bp<0.001 vs control; one way ANOVA followed by Tukey’s multiple range test 
 
 
Fig. 3: Antidepressant activity profile of total ash of H. sabdariffa calyces using FST. The data is expressed as mean±SEM; *n=6; ap<0.001 vs 
control; bp<0.001 vs imipramine; one way ANOVA followed by Tukey’s multiple range test 
 
 
Fig. 4: Antidepressant activity profile of placebo and H. sabdariffa total ash tablet using FST. The data is expressed as mean±SEM; *n=6; 
ap<0.001 vs imipramine; bp<0.001 vs control; one way ANOVA followed by Tukey’s multiple range test 
Ashwani et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 4, 33-38 
37 
 
Fig. 5: Antianxiety activity profile of major elements present in the total ash of H. sabdariffa calyces, using EPM. The data is expressed as 
mean±SEM; *n=6; ap<0.001 vs diazepam; bp<0.001 vs control; one way ANOVA followed by Tukey’s multiple range test 
 
 
Fig. 6: Antidepressant activity profile of major elements present in the total ash of H. sabdariffa calyces, using FST. The data is expressed 
as mean±SEM; *n=6; ap<0.001 vs imipramine; bp<0.001 vs control; one way ANOVA followed by Tukey’s multiple range test 
 
Elemental analysis of total-ash: ICP-MS technique 
Results of the ICP-MS of total ash of H. sabdariffa calyces evinced K, 
Mg and Ca to be the elements with maximum % concentration. Table 
5 shows the percentage concentration of different elements in the 
total-ash of H. sabdariffa calyces.  
Antianxiety and antidepressant activity evaluation of salts of 
major elements present in total ash of H. sabdariffa calyces 
The salts of major elements exhibited significant antianxiety and 
antidepressant activity, comparable to the standard anxiolytic and 
antidepressant agents, respectively. The results of antianxiety and 
antidepressant activity are depicted in fig. 5 and 6, respectively. 
DISCUSSION 
Results of the present study indicate that the total ash of H. 
sabdariffa calyces exhibit significant antianxiety and antidepressant 
activity at 50 and 100 mg/kg, respectively. The activities were 
comparable to the standard antianxiety and antidepressant drugs 
diazepam and imipramine, respectively. However, the major concern 
associated with powder formulations is ingestion of exact dose and 
low palatability. Thus, to overcome this problem, the total ash of H. 
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sabdariffa calyces was formulated into tablets using organic 
excipients to prevent any elevation or diminution of activity due to 
inorganic excipients. Prior to the formulation of tablets, various pre-
formulation parameters (angle of repose, bulk density, tapped 
density, Hausner’s ratio and Carr’s index) were evaluated for 
determining the physical properties of active ingredients and 
excipients. Both the placebo and H. sabdariffa total ash tablets 
conformed to the prescribed norms for the pre-formulation studies. 
Further, the post formulation parameters were evaluated for the 
placebo and H. sabdariffa total ash tablets to check any defects in the 
structural integrity of the tablets, and to determine the uniformity of 
content of the tablets. Both placebo and H. sabdariffa total ash 
tablets were observed to conform to the laid down standards. The 
tablets were subjected to antianxiety and antidepressant activity 
evaluation to compare its activity with that of the total ash, and to 
observe if there were any changes due to the excipients added in the 
tablets. Tablet of H. sabdariffa total ash exhibited the same level of 
antianxiety and antidepressant activity as that of the total ash. 
However, as expected, placebo tablets were devoid of these 
activities.  
Results of the ICP-MS analysis evinced K, Mg and Ca to be the major 
elements in the total ash of H. sabdariffa calyces. Numerous studies 
have indicated that Mg, K and Ca play significant role in the 
pathogenesis of anxiety and depression and deficiencies of these are 
known to trigger the symptoms of anxiety or depression [9, 10]. 
Thus, to ascertain their role in anxiety and depression, the 
antianxiety and antidepressant activity of commonly available 
salts of Mg, K and Ca, i.e., MgSO4, K2SO4 and CaCO3 were evaluated. 
The dose of various elements was selected based on the relative % 
concentration of the three major elements (Mg, K and Ca) in the 
total ash of the plant material. The three salts exhibited significant 
antianxiety and antidepressant activity at their respective doses. 
Thus, the antianxiety and antidepressant activity of H. sabdariffa 
total ash may be attributed to high concentrations of Mg, K and Ca; 
which are known to have a significant role in affective disorders 
[9, 10].  
CONCLUSION 
The present study indicates that total ash of H. sabdariffa calyces 
exhibits significant antianxiety and antidepressant activity in mice 
on EPM and FST, respectively. Also, the antianxiety and 
antidepressant activity of the total ash may be attributed to the 
elements, majorly magnesium, potassium and calcium, which are 
known to have significant role in pathogenesis of affective disorders. 
Thus, the results substantiate the role of elements in affective 
disorders. 
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